Zdrowie i gospodarka · 29/06/2004

FDA Extends Digoxin Elixir Marketing Approval Deadline

The FDA has granted an extension to manufacturers of digoxin elixir, allowing them to continue marketing the products without approved applications until December 28, 2004, to give them additional time to obtain marketing approval and bring products to market.